Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute.
-
Second-hand smoke exposure has fallen by 50 percent since 1999, a new study finds, but millions are still routinely exposed to secondhand smoke.
-
Palbociclib (Ibrance) is approved to be used in combination with letrozole (Femara) to treat postmenopausal women with metastatic breast cancer.
-
For the first time, Medicare will cover the costs of lung cancer screening for some beneficiaries, the Centers for Medicare and Medicaid Services (CMS) announced on February 5.
-
Researchers have surveyed the genetic changes in nearly 300 head and neck cancers, revealing some previously unknown alterations that may play a role in the disease, including in patients whose cancer is associated with the human papillomavirus (HPV).
-
Under the Precision Medicine Initiative, NCI is working to accelerate the pace of research that will help identify which treatments work best for which patients.
-
In 2014, the Food and Drug Administration (FDA) approved 41 drugs that had not been approved previously for any indication, the most in nearly 20 years. Of these 41 novel drugs, 9 were approved for the treatment of cancer or cancer-related conditions.
-
A new study suggests that dense bacterial communities called biofilms may promote the development of some colorectal cancers.
-
New research suggests that identifying specific changes in the gut microbiome could potentially help screen patients for colorectal cancer.
-
The first report of its kind finds that more than 300 million people worldwide use smokeless tobacco products and that they are linked to a number of cancers.
-
Several new resources that provide more details about the changing treatment landscape for advanced melanoma have recently been added to Cancer.gov.